Conjoint Professor David Henry

Conjoint Professor

School of Medicine and Public Health

Career Summary

Biography

Research Expertise

Evidence based medicine, adverse drug reactions pharmacovigilance, pharmaco-epidemiology and pharmaco-economics



Teaching Expertise

Clinical medicine, clinical pharmacology, rational drug use, pharmaco-epidemiology and pharmaco-economics



Administrative Expertise

I have been discipline head since 1997 and have also served as Head of School (Population Health Sciences) and deputy head of school (Medicine and Population Health) at different times. I am Director of the Newcastle Institute of Public Health and Director of the WHO Collaborating Centre for Training in Pharmaco-economics and Rational Pharmacotherapy at the University of Newcastle. I am chair of medical staff council of the Newcastle Mater Hospital and have served on multiple committees, including ethics committees of the University and health service. I have been a member of several national committees concerned with drug regulation and for 8 years chaired the economics subcommittee of the Commonwealth governments Pharmaceutical Benefits Advisory Committee


Qualifications

  • Bachelor of Medicine, Bachelor of Surgery, University of Glasgow - Scotland

Keywords

  • Clinical Pharmacology
  • General Medicine
  • Pharmaco-economics
  • Pharmaco-epidemiology

Fields of Research

CodeDescriptionPercentage
160508Health Policy25
110399Clinical Sciences not elsewhere classified35
111799Public Health and Health Services not elsewhere classified40

Professional Experience

UON Appointment

DatesTitleOrganisation / Department
1/01/2006 - 31/08/2007ProfessorUniversity of Newcastle
School of Medicine and Public Health
Australia

Academic appointment

DatesTitleOrganisation / Department
Director - World Health Organisation Collaborating Centre for Training in Pharmo-economics and Rational PharmacotherapyWorld Health Organisation Collaborating Centre
Australia
1/01/2007 - ChairMedical Staff Council, Newcastle Mater Hospital
Australia
1/02/1983 - 1/08/1996Senior Lecturer in Clinical PharmacologyUniversity of Newcastle
School of Medicine and Public Health
Australia
1/01/1978 - 1/02/1983Lecturer in TherapeuticsThe University of Nottingham
Department of Therapeutics
United Kingdom

Membership

DatesTitleOrganisation / Department
Member, Panel of Referees for Project Grants - Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)
Canada
Member - South African National Medicines Pricing CommitteeSouth African National Medicines Pricing Committee
South Africa
Member, Panel of Referees for Project Grants - National Health and Medical Research CouncilNational Health and Medical Research Council
Australia
Member, Panel of Referees for Project Grants - Medical Research Council of New ZealandMedical Research Council of New Zealand
New Zealand
Member, Panel of Referees for Project Grants - Medical Research Council (UK)Medical Research Council of the United Kingdom
United Kingdom
Member - International Society of PharmacoepidemiologyInternational Society of Pharmacoepidemiology
Australia
Member - Australasian Society of Clinical and Experimental PharamcologistsAustralasian Society of Clinical and Experimental Pharamcologists
Australia

Awards

Recipient

YearAward
2005Eureka Skeptics Prize for Critical Thinking
Australian Museum
2001Thomas Chalmers Memorial Award
Unknown

Invitations

Participant

YearTitle / Rationale
2007Pharmaco-economics
Organisation: World Health Organisation
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Chapter (6 outputs)

YearCitationAltmetricsLink
2005Henry DA, McGettigan PG, Anne T, Sean H, 'Basic principles of clinical pharmacology relevant to pharmacoepidemiology studies', Pharmacoepidemiology, John Wiley & Sons, Hoboken 867 (2005) [B1]
Co-authorsMddah01
2001O'Connell DL, Glasziou P, Hill SR, Sarunac J, Lowe J, Henry DA, 'Results of Clinical Trials and Systematic Reviews: To Whom Do They Apply?', The Advanced Handbook of Methods in Evidence Based Healthcare, Sage Publications Ltd, London England 56-72 (2001) [B1]
Co-authorsMddah01
2001Hill SR, Henry DA, Stevens A, 'The use of evidence in drug selection: The Australian Pharmaceutical Benefits Scheme', Informing Judgment: Case Studies of Health Policy and Research in Six Countries, Milbank Memorial Fund, U.S.A. 7-27 (2001) [B2]
Co-authorsMddah01
2000McGettigan PG, Henry DA, Hennessy S, 'Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies', Pharmacoepidemiology, John Wiley & Sons, West Sussex. England 41-62 (2000) [B1]
Co-authorsMddah01
2000Hill SR, Henry DA, 'National Medicinal Drug Policies: their Relationship to Pharmacoepidemiology', Pharmacoepidemiology, John Wiley & Sons Ltd, Great Britain 433-447 (2000) [B1]
Co-authorsMddah01
1999Henry DA, Drew A, Beuzeville S, 'Gastrointestinal Adverse Drug Reactions Attributed to Ibuprofen', Ibuprofen A critical bibliographic review, T.J. International Ltd., Cornwall UK 431-458 (1999) [B1]
Co-authorsMddah01
Show 3 more chapters

Journal article (116 outputs)

YearCitationAltmetricsLink
2014Robertson J, Doran E, Henry DA, Salkeld G, 'Prescription medicines: Decision-making preferences of patients who receive different levels of public subsidy', Health Expectations, 17 15-26 (2014) [C1]

Objective To compare the relative importance of medicine attributes and decision-making preferences of patients with higher or lower levels of insurance coverage in a publicly funded health care system. Design and setting Cross-sectional telephone survey of randomly selected regular medicine users aged =18years in the Hunter Valley, NSW, Australia. Main variables studied Questions about 27 medicine attributes and active involvement in decisions to start a new medicine. Results After adjustment, there were few differences between the 408 concession card holders (high insurance) and 410 general beneficiaries (low insurance) in their assessment of the importance of medicine attributes. For both groups, the explanation of treatment options, establishing the need for the medicine, and medicine efficacy and safety were the most important considerations. Medicine costs, the treatment burden and medicine familiarity were less important; the views of family and friends ranked lowest. There was a statistically significantly greater influence of the regular doctor for the concession card holders than general beneficiaries (93.6 vs. 84%, adjusted OR 2.80, 95% CI 1.31, 5.99). Concession card holders were more likely to favour doctors having more say in the decision-making process (crude OR 1.69, 95% CI 1.28, 2.24), and more likely to report the most recent treatment decision being made by the doctor alone, compared with general beneficiaries (61.2 vs. 40.3%). Conclusion Medicine need, efficacy and safety are viewed as paramount for most patients, irrespective of insurance status. While patients report the importance of participation in treatment decisions, delegation of decision making to the doctor was common in practice. © 2011 John Wiley & Sons Ltd.

DOI10.1111/j.1369-7625.2011.00715.x
CitationsScopus - 1Web of Science - 1
Co-authorsMddah01
2014Robertson J, Doran E, Henry DA, Salkeld G, 'Prescription medicines: Decision-making preferences of patients who receive different levels of public subsidy', Health Expectations, 17 15-26 (2014) [C1]

Objective To compare the relative importance of medicine attributes and decision-making preferences of patients with higher or lower levels of insurance coverage in a publicly funded health care system. Design and setting Cross-sectional telephone survey of randomly selected regular medicine users aged =18years in the Hunter Valley, NSW, Australia. Main variables studied Questions about 27 medicine attributes and active involvement in decisions to start a new medicine. Results After adjustment, there were few differences between the 408 concession card holders (high insurance) and 410 general beneficiaries (low insurance) in their assessment of the importance of medicine attributes. For both groups, the explanation of treatment options, establishing the need for the medicine, and medicine efficacy and safety were the most important considerations. Medicine costs, the treatment burden and medicine familiarity were less important; the views of family and friends ranked lowest. There was a statistically significantly greater influence of the regular doctor for the concession card holders than general beneficiaries (93.6 vs. 84%, adjusted OR 2.80, 95% CI 1.31, 5.99). Concession card holders were more likely to favour doctors having more say in the decision-making process (crude OR 1.69, 95% CI 1.28, 2.24), and more likely to report the most recent treatment decision being made by the doctor alone, compared with general beneficiaries (61.2 vs. 40.3%). Conclusion Medicine need, efficacy and safety are viewed as paramount for most patients, irrespective of insurance status. While patients report the importance of participation in treatment decisions, delegation of decision making to the doctor was common in practice. © 2011 John Wiley & Sons Ltd.

DOI10.1111/j.1369-7625.2011.00715.x
CitationsScopus - 1
Co-authorsMddah01
2014Gershon AS, Khan S, Klein-Geltink J, Wilton D, To T, Crighton EJ, et al., 'Asthma and Chronic Obstructive Pulmonary Disease (COPD) Prevalence and Health Services Use in Ontario Metis: A Population-Based Cohort Study', PLOS ONE, 9 (2014) [C1]
DOI10.1371/journal.pone.0095899Author URL
CitationsScopus - 3Web of Science - 2
Co-authorsMddah01
2013Stukel TA, Glazier RH, Schultz SE, Guan J, Zagorski BM, Gozdyra P, Henry DA, 'Multispecialty physician networks in Ontario', Open Medicine, 7 1-16 (2013) [C1]
CitationsScopus - 1
Co-authorsMddah01
2013Searles A, Doran E, Faunce TA, Henry D, 'The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?', AUSTRALIAN HEALTH REVIEW, 37 32-40 (2013) [C1]
DOI10.1071/AH11153Author URL
CitationsScopus - 1Web of Science - 1
Co-authorsMddah01
2013Robertson J, McElduff P, Pearson S-A, Henry DA, Inder KJ, Attia JR, 'The health services burden of heart failure: an analysis using linked population health data-sets (vol 12, pg 103, 2012)', BMC HEALTH SERVICES RESEARCH, 13 (2013) [O1]
DOI10.1186/1472-6963-13-179Author URL
Co-authorsMddah01, John Attia, Kerry Inder
2011McGettigan P, Henry DA, 'Cardiovascular risk with non-steroidal anti-inflammatory drugs: Systematic review of population-based controlled observational studies', PloS Medicine, 8 e1001098 (2011) [C1]
CitationsScopus - 158Web of Science - 103
Co-authorsMddah01
2011McGettigan P, Lincz L, Attia JR, McElduff P, Bissett L, Peel R, et al., 'The risk of coronary thrombosis with cyclo-oxygenase-2 inhibitors does not vary with polymorphisms in two regions of the cyclo-oxygenase-2 gene', British Journal of Clinical Pharmacology, 72 707-714 (2011) [C1]
DOI10.1111/j.1365-2125.2011.03957.x
CitationsScopus - 6Web of Science - 6
Co-authorsLisa Lincz, Roseanne Peel, John Attia, Barrie Stokes, Mddah01
2010Lee DS, Stukel TA, Austin PC, Alter DA, Schull MJ, You JJ, et al., 'Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department', Circulation, 122 1806-1814 (2010) [C1]
DOI10.1161/CIRCULATIONAHA.110.940262
CitationsScopus - 38Web of Science - 37
Co-authorsMddah01
2010Wilson AJ, Robertson J, McElduff P, Jones AL, Henry DA, 'Does it matter who writes medical news stories?', PLoS Medicine, 7 1-5 (2010) [C1]
DOI10.1371/journal.pmed.1000323
CitationsScopus - 8Web of Science - 3
Co-authorsMddah01, Amanda Wilson
2010Henry DA, 'Doctors and drug companies: Still cozy after all these years', PLoS Medicine, 7 1-2 (2010) [C3]
CitationsScopus - 2
Co-authorsMddah01
2010Wilson AJ, Bonevski B, Jones AL, Henry DA, 'Deconstructing cancer: What makes a good-quality news story?', Medical Journal of Australia, 193 702-706 (2010) [C1]
CitationsScopus - 1Web of Science - 1
Co-authorsMddah01, Billie Bonevski, Amanda Wilson
2010McEvoy MA, Smith WT, D'Este CA, Duke JM, Peel R, Schofield PW, et al., 'Cohort Profile: The Hunter Community Study', International Journal of Epidemiology, 39 1452-1463 (2010) [C1]
DOI10.1093/ije/dyp343
CitationsScopus - 52Web of Science - 51
Co-authorsWayne Smith, Catherine Deste, Ben Ewald, Julie Byles, Rodney Scott, Roseanne Peel, Derek Smith, Peter Schofield, Mddah01, John Attia
2010Robertson J, Walkom EJ, Moynihan R, Bero L, Henry DA, 'Pharmaceutical industry funding of educational events for pharmacists in Australia: An analysis of data from the first 6 months of a mandatory disclosure programme', International Journal of Pharmacy Practice, 18 88-92 (2010) [C1]
DOI10.1211/ijpp/18.02.0003
Co-authorsMddah01
2010Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry DA, et al., 'IQWiG methods - A response to two critiques', Health Economics, 19 1137-1138 (2010) [C3]
CitationsScopus - 4Web of Science - 1
Co-authorsMddah01
2010Caro JJ, Nord E, Siebert U, McGuire A, McGregor M, Henry DA, et al., 'The efficiency frontier approach to economic evaluation of health-care interventions', Health Economics, 19 1117-1127 (2010) [C1]
DOI10.1002/hec.1629
CitationsScopus - 35Web of Science - 26
Co-authorsMddah01
2010Macneill PU, Kerridge IH, Newby DA, Stokes BJ, Doran E, Henry DA, 'Attitudes of physicians and public to pharmaceutical industry 'gifts'', Internal Medicine Journal, 40 335-341 (2010) [C1]
DOI10.1111/j.1445-5994.2010.02233.x
CitationsScopus - 9Web of Science - 6
Co-authorsBarrie Stokes, David Newby, Mddah01
2010Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA, 'Cell salvage for minimising perioperative allogeneic blood transfusion', Cochrane Database of Systematic Reviews, 1-181 (2010) [C1]
DOI10.1002/14651858.CD001888.pub3
CitationsScopus - 46Web of Science - 15
Co-authorsMddah01
2010Carless PA, Henry DA, Carson JL, Hebert PPC, McClelland B, Ker K, 'Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion', Cochrane Database of Systematic Reviews, CD002042 (2010) [C1]
DOI10.1002/14651858.CD002042.pub2
CitationsScopus - 30Web of Science - 23
Co-authorsMddah01
2009Robertson J, Moynihan R, Walkom EJ, Bero L, Henry DA, 'Mandatory disclosure of pharmaceutical industry-funded events for health professionals', PLoS Medicine, 6 e1000128 (2009) [C1]
DOI10.1371/journal.pmed.1000128
CitationsScopus - 7Web of Science - 2
Co-authorsMddah01
2009Henry DA, Carless PA, Fergusson D, Laupacis A, 'The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: A meta-analysis', Canadian Medical Association Journal, 180 183-193 (2009) [C1]
DOI10.1503/cmaj.081109
CitationsScopus - 96Web of Science - 74
Co-authorsMddah01
2008Doran E, Henry DA, 'Disease mongering: Expanding the boundaries of treatable disease', Internal Medicine Journal, 38 858-861 (2008) [C1]
DOI10.1111/j.1445-5994.2008.01814.x
CitationsScopus - 10Web of Science - 10
Co-authorsMddah01
2008Moynihan R, Doran E, Henry DA, 'Disease mongering is now part of the global health debate', PLoS Medicine, 5 0684-686 (2008) [C2]
DOI10.1371/journal.pmed.0050106
CitationsScopus - 21Web of Science - 12
Co-authorsMddah01
2008Wodak AD, Ali R, Henry DA, Sansom L, 'Ensuring the safety of new medications and devices: Are naltrexone implants safe?', Medical Journal of Australia, 188 438-439 (2008) [C3]
Co-authorsMddah01
2008Doran E, Henry DA, Faunce TA, Searles AM, 'Australian pharmaceutical policy and the idea of innovation', Journal of Australian Political Economy, 62 39-61 (2008) [C1]
CitationsScopus - 2Web of Science - 1
Co-authorsMddah01
2008Doran E, Henry DA, 'Australian pharmaceutical policy: Price control, equity, and drug innovation in Australia', Journal of Public Health Policy, 29 106-120 (2008) [C1]
DOI10.1057/palgrave.jphp.3200170
CitationsScopus - 12Web of Science - 9
Co-authorsMddah01
2008McGettigan PG, Han PY, Jones LJ, Whitaker DE, Henry DA, 'Selective COX-2 inhibitors, NSAIDs and congestive heart failure: Differences between new and recurrent cases', British Journal of Clinical Pharmacology, 65 927-934 (2008) [C1]
DOI10.1111/j.1365-2125.2008.03121.x
CitationsScopus - 15Web of Science - 13
Co-authorsMddah01
2007Pearson SA, Ringland C, Kelman C, Mant A, Lowinger J, Stark H, et al., 'Patterns of analgesic and anti-inflammatory medicine use by Australian veterans', Internal Medicine Journal, 37 798-805 (2007) [C1]
DOI10.1111/j.1445-5994.2007.01516.x
CitationsScopus - 8Web of Science - 7
Co-authorsMddah01
2007Henry DA, Carless PA, Moxey AJ, O'Connell DL, Stokes BJ, McClelland B, et al., 'Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion', The Cochrane Database of Systematic Reviews, CD001886 (2007) [C1]
DOI10.1002/14651858.cd001886.pub2
CitationsScopus - 22Web of Science - 84
Co-authorsMddah01, Barrie Stokes
2007Salkeld G, Henry DA, Hill SR, Lang DL, Freemantle N, D'Assuncao J, 'What drives health-care spending priorities? An international survey of health-care professionals', Plos Medicine, 4 256-259 (2007) [C1]
DOI10.1371/journal.pmed.0040094
Co-authorsMddah01
2007Henry DA, McGettigan PG, 'Selective COX-2 inhibitors: A promise unfulfilled?', Gastroenterology, 132 790-794 (2007) [C3]
Co-authorsMddah01
2007Kelman CW, Pearson SA, Day RO, D'Arcy C, Holman J, Kliewer EV, Henry DA, 'Evaluating medicines: let's use all the evidence', Medical Journal of Australia, 186 249-252 (2007) [C1]
CitationsScopus - 22Web of Science - 19
Co-authorsMddah01
2007Pit SW, Byles JE, Henry DA, Holt L, Hansen V, Bowman DA, 'A Quality Use of Medicines program for general practitioners and older people: A cluster randomised controlled trial', Medical Journal of Australia, 187 23-30 (2007) [C1]
CitationsScopus - 52Web of Science - 46
Co-authorsMddah01, Julie Byles
2007Searles AM, Jefferys S, Doran E, Henry DA, 'Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme', Medical Journal of Australia, 187 236-239 (2007) [C1]
CitationsScopus - 14Web of Science - 14
Co-authorsMddah01
2007Henry DA, McGettigan PG, 'Cyclooxygenase inhibitors and cardiovascular risk - Reply', JAMA - Journal of the American Medical Association, 297 587-588 (2007) [C3]
Co-authorsMddah01
2006McGettigan PG, Henry DA, 'Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase', JAMA - Journal of the American Medical Association, 296 1633-1644 (2006) [C1]
DOI10.1001/jama.296.13.jrv60011
Co-authorsMddah01
2006Doran E, Kerridge I, McNeill P, Henry DA, 'Empirical uncertainty and moral contest: A qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia', Social Science & Medicine, 62 1510-1519 (2006) [C1]
DOI10.1016/j.socscimed.2005.07.037
CitationsScopus - 22Web of Science - 14
Co-authorsMddah01
2006McGettigan PG, Han PY, Henry DA, 'Cyclooxygenase-2 inhibitors and coronary occlusion - Exploring dose-response relationships', British Journal of Clinical Pharmacology, 62 358-365 (2006) [C1]
DOI10.1111/j.1365-2125.2006.02660.x
Co-authorsMddah01
2006Carless PA, Henry DA, 'Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery', British Journal of Surgery, 93 810-819 (2006) [C1]
DOI10.1002/bjs.5432
CitationsScopus - 58Web of Science - 49
Co-authorsMddah01
2006McNeill PM, Kerridge IH, Henry DA, Stokes BJ, Hill SR, Newby DA, et al., 'Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia', Internal Medicine Journal, 36 571-578 (2006) [C1]
DOI10.1111/j.1445-5994.2006.01151.x
CitationsScopus - 19Web of Science - 17
Co-authorsJane Maguire, Barrie Stokes, Mddah01, David Newby
2006Doran E, Henry DA, 'Pharmaceutical benefits scheme policy: confused and tough on patients (Editorial)', Internal Medicine Journal, 36 211-213 (2006) [C3]
CitationsScopus - 5Web of Science - 4
Co-authorsMddah01
2006McNeill PM, Kerridge I, Henry DA, 'Reply', Internal Medicine Journal, 36 796-797 (2006) [C3]
Co-authorsMddah01
2006Carless PA, Henry DA, Moxey AJ, O'Connell DL, Brown T, Fergusson DA, 'Cell Salvage for Minimising Perioperative Allogeneic Blood Transfusion', Cochrane Database of Systematic Reviews, 4 (2006) [C1]
DOI10.1002/14651858.CD001888
CitationsScopus - 27Web of Science - 5
Co-authorsMddah01
2006Harris A, Hill SR, Henry DA, 'Cost-effectiveness and resource allocation - Reply', JAMA - Journal of the American Medical Association, 295 2723-2724 (2006) [C3]
CitationsScopus - 1
Co-authorsMddah01
2006Moynihan R, Henry DA, 'The fight against disease mongering: Generating knowledge for action', Plos Medicine, 3 e191 (2006) [C2]
CitationsScopus - 111
Co-authorsMddah01
2005Henry DA, Doran E, Kerridge I, Hill SR, McNeill PM, Day R, 'Ties that bind - Multiple relationships between clinical researchers and the pharmaceutical industry', Archives of Internal Medicine, 165 2493-2496 (2005) [C1]
DOI10.1001/archinte.165.21.2493
CitationsScopus - 14Web of Science - 11
Co-authorsMddah01
2005Henry DA, Kerridge IH, Hill SR, McNeill PM, Doran E, Newby DA, et al., 'Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience', Medical Journal of Australia, 182 557-560 (2005) [C1]
CitationsScopus - 29Web of Science - 27
Co-authorsBarrie Stokes, Jane Maguire, David Newby, Mddah01
2005Smith DE, Wilson AJ, Henry DA, 'Monitoring the quality of medical news reporting: Early experience with media doctor', Medical Journal of Australia, 183 190-193 (2005) [C1]
CitationsScopus - 33Web of Science - 31
Co-authorsMddah01, Amanda Wilson
2005Moxey AJ, O'Connell DL, Treloar CJ, Han PYS, Henry DA, 'Blood transfusion and autologous donation: a survey of post-surgical patients, interest group members and the public', Transfusion Medicine, 15 19-32 (2005) [C1]
DOI10.1111/j.1365-3148.2005.00544.x
CitationsScopus - 9Web of Science - 10
Co-authorsMddah01
2005Carless PA, Henry DA, 'Systematic review of autologous transfusion techniques (Reply)', Transfusion Medicine, 15 256-256 (2005) [C3]
Co-authorsMddah01
2005Kerridge I, Maguire JM, Newby DA, McNeill PM, Henry DA, Hill SR, et al., 'Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations', Internal Medicine Journal, 35 206-210 (2005) [C1]
DOI10.1111/j.1444-0903.2004.00799.x
CitationsScopus - 11Web of Science - 6
Co-authorsJane Maguire, Barrie Stokes, Mddah01, David Newby
2005Day RO, Birkett DJ, Miners J, Shenfield GM, Henry DA, Seale JP, 'Access to medicines and high-quality therapeutics: Global responsibilities for clinical pharmacology (Conference report)', Medical Journal of Australia, 182 322-323 (2005) [C1]
CitationsWeb of Science - 5
Co-authorsMddah01
2005Carless PA, Moxey AJ, Stokes BJ, Henry DA, 'Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials', BMC Cardiovascular Disorders, 5 (2005) [C1]
DOI10.1186/1471-2261-5-19
CitationsScopus - 47
Co-authorsBarrie Stokes, Mddah01
2005McGettigan PG, Henry DA, 'Medical research and the news media', New England Journal of Medicine, 352 838-840 (2005) [C1]
DOI10.1056/NEJM200502243520821
Co-authorsMddah01
2005Henry DA, Hill SR, Harris A, 'Drug prices and value for money: The Australian Pharmaceutical Benefits Scheme (Commentary)', Journal of the American Medical Association, 294 2630-2632 (2005) [C1]
DOI10.1001/jama.294.20.2630
CitationsScopus - 60Web of Science - 47
Co-authorsMddah01
2005Schwitzer G, Mudur G, Henry DA, Wilson AJ, Goozner M, Simbra M, et al., 'What are the roles and responsibilities of the media in disseminating health information?', Plos Medicine, 2 576-582 (2005) [C1]
DOI10.1371/journal.pmed.0020215
CitationsScopus - 39Web of Science - 31
Co-authorsMddah01, Amanda Wilson
2005Faunce T, Doran E, Henry DA, Drahos P, Searles A, Pekarsky B, Neville W, 'Assessing the impact of the Australian-United States free trade agreement on Australian and global medicines policy', Globalization and Health, 1 (2005) [C1]
DOI10.1186/1744-8603-1-15
CitationsScopus - 19Web of Science - 9
Co-authorsMddah01
2004Mansfield P, Henry DA, Tonkin A, 'Single-Enantiomer Drugs. Elegant Science, Disappointing Effects', Clinical Pharmacokinetics, 43 287-290 (2004) [C1]
DOI10.2165/00003088-200443050-00002
Co-authorsMddah01
2004Drahos P, Lokuge B, Faunce T, Goddard M, Henry DA, 'Pharmaceuticals, Intellectual Property and Free Trade: The Case of the US-Australia Free Trade Agreement', Prometheus, 22 243-257 (2004) [C1]
DOI10.1080/0810902042000255705
Co-authorsMddah01
2004Carless PA, Moxey AJ, O'Connell DL, Henry DA, 'Autologous transfusion techniques: systematic review of their efficacy', Transfusion Medicine, 14 123-144 (2004) [C1]
DOI10.1111/j.0958-7578.2004.0489.x
CitationsScopus - 79Web of Science - 64
Co-authorsMddah01
2004Drahos P, Henry DA, 'The free trade agreement between Australia and the United States, Undermines Australian public health and protects US interests in pharmaceuticals', BMJ, 328 1271-1272 (2004) [C3]
Co-authorsMddah01
2004Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al., 'Grading quality of evidence and strength of recommendations', BMJ, 328 1-8 (2004) [C1]
DOI10.1136/bmj.328.7454.1490
Co-authorsMddah01
2004Mansfield PR, Henry DA, 'Misleading drug promotion- no sign of improvements', Pharmacoepidemiology and drug safety, 13 797-799 (2004) [C3]
Co-authorsMddah01
2004Doran E, Robertson J, Rolfe IE, Henry DA, 'Patient co-payments and use of prescription medicines', Australian and New Zealand Journal of Public Health, 28 62-67 (2004) [C1]
DOI10.1111/j.1467-842X.2004.tb00634.x
CitationsScopus - 25Web of Science - 23
Co-authorsMddah01
2004Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry DA, Hill SR, et al., 'Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group', BMC Health Services Research, 4 1-7 (2004) [C1]
DOI10.1186/1472-6963-4-38
CitationsScopus - 277Web of Science - 261
Co-authorsMddah01
2003Henry DA, McGettigan PG, 'Epidemiology overview of gastrointestinal and renal toxicity of NSAIDs', International Journal of Clinical Practice, 135 43-49 (2003) [C1]
Co-authorsMddah01
2003Henry DA, Lang DL, 'Published pharmacoeconomic analyses: science or marketing?', Internal Medicine Journal, 33 404-404 (2003) [C3]
Co-authorsMddah01
2003Carless PA, Rubens FD, Anthony DM, O'Connell DL, Henry DA, 'Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion', Cochrane Database of Systematic Reviews, - CD004172 (2003) [C1]
DOI10.1002/14651858.cd004172
CitationsScopus - 2
Co-authorsMddah01
2003Carless PA, Henry DA, Anthony DM, 'Fibrin sealant use for minimising peri-operative allogeneic blood transfusion', Cochrane Database of Systematic Reviews, 4 (2003) [C3]
CitationsScopus - 7
Co-authorsMddah01
2003Newby DA, Fryer JL, Henry DA, 'Effect of computerised prescribing on use of antibiotics', Medical Journal of Australia, 178 210-213 (2003) [C1]
CitationsScopus - 12Web of Science - 9
Co-authorsMddah01, David Newby
2003Doran E, Henry DA, 'The PBS community awareness campaign: how helpful is blaming patients', Medical Journal of Australia, 179 544-545 (2003) [C1]
CitationsScopus - 10Web of Science - 8
Co-authorsMddah01
2003Henry DA, Salkeld G, 'Bridges to Iran', The Lancet, 361 438 (2003) [C3]
Co-authorsMddah01
2003Henry DA, Lexchin J, 'Patent law', The Lancet, 361 1059 (2003) [C3]
DOI10.1016/s0140-6736(03)12810-3
Co-authorsMddah01
2003Henry DA, Lexchin J, 'Pfizer Diflucan Partnership Program: Authors' reply', The Lancet, 361 72 (2003) [C3]
DOI10.1016/s0140-6736(03)12125-3
Co-authorsMddah01
2003Robertson J, Treloar CJ, Sprogis A, Henry DA, 'The influence of specialists on prescribing GPs: A qualitative study', Australian Family Physician, 32 573-576 (2003) [C1]
CitationsScopus - 15
Co-authorsMddah01
2003Moxey AJ, O'Connell DL, McGettigan PG, Henry DA, 'Describing treatment effects to patients: How they are expressed makes a difference', Journal of General Internal Medicine, 18 948-959 (2003) [C1]
DOI10.1046/j.1525-1497.2003.20928.x
CitationsScopus - 67Web of Science - 58
Co-authorsMddah01
2003Lelorier J, Vander Stichele RH, Avorn J, Beard K, Hallas J, Henry DA, 'Bringing epidemology into drug utilisation research', Pharmacoepidemiology & Drug Safety: an International Journal, 12 153-156 (2003) [C1]
DOI10.1002/pds.817
CitationsScopus - 1Web of Science - 1
Co-authorsMddah01
2002Carless PA, Anthony DM, Henry DA, 'Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion', British Journal of Surgery, 89 695-703 (2002) [C1]
CitationsScopus - 62Web of Science - 47
Co-authorsMddah01
2002Robertson J, Fryer JL, O'Connell DL, Smith AN, Henry DA, 'Limitations of Health Insurance Commission (HIC) data for deriving prescribing indicators', Medical Journal of Australia, 176 419-424 (2002) [C1]
CitationsScopus - 14Web of Science - 13
Co-authorsMddah01
2002Newby DA, Henry DA, 'Drug advertising: truths, half-truths and few statistics', Medical Journal of Australia, 177(6) 285-286 (2002) [C3]
CitationsScopus - 5Web of Science - 2
Co-authorsDavid Newby, Mddah01
2002Lopert R, Lang DL, Hill SR, Henry DA, 'Differential pricing of drugs: a role for cost-effectiveness analysis?', The Lancet, 359 2105-2107 (2002) [C1]
CitationsScopus - 17Web of Science - 14
Co-authorsMddah01
2002Henry DA, Lexchin J, 'The Pharmaceutical Industry as a medicines provider', The Lancet, 360 1590-1595 (2002) [C1]
Co-authorsMddah01
2002Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, et al., 'V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women', Endocrine Reviews, 23(4) 529-539 (2002) [C1]
Co-authorsMddah01
2002Lopert R, Henry DA, 'The Pharmaceutical Benefits Scheme: economic evaluation works ... but is not a panacea', Australian Prescriber, 25(6) 126-127 (2002) [C1]
Co-authorsMddah01
2002Carson J, Hill SR, Carless PA, Hebert P, Henry DA, 'Transfusion Triggers: a systematic review of the literature', Transfusion Medicine Reviews, 16(3) 187-199 (2002) [C1]
DOI10.1053/tmrv.2002.33461
Co-authorsMddah01
2002Moynihan R, Heath I, Henry DA, 'Selling sickness: The pharmaceutical industry and disease mongering', British Medical Journal, 324 886-891 (2002) [C1]
CitationsScopus - 432Web of Science - 318
Co-authorsMddah01
2002Henry DA, Carless PA, Moxey A, O'Connell DL, Forgie M, Wells P, Fergusson D, 'Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion', The Cochrane Library, 2002 Issue 4 On-line (2002) [C3]
CitationsScopus - 9
Co-authorsMddah01
2002Hill SR, Carless PA, Henry DA, Carson J, Hebert P, McClelland D, Henderson K, 'Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion', The Cochrane Library, 2002 Issue 4 On-line (2002) [C3]
CitationsScopus - 54
Co-authorsMddah01
2001Robertson J, Fryer JL, O'Connell DL, Sprogis A, Henry DA, 'The impact of specialists on prescribing by general practitioners', Medical Journal of Australia, 175 407-411 (2001) [C1]
CitationsScopus - 23Web of Science - 18
Co-authorsMddah01
2001Henry DA, Birkett D, 'Changes to the Pharmaceutical Benefits Advisory Committee', Medical Journal of Australia, 174(5) 209-210 (2001) [C3]
CitationsScopus - 9Web of Science - 8
Co-authorsMddah01
2001Robertson J, Fryer JL, O'Connell DL, Smith AN, Henry DA, 'Personal Formularies. An index of prescribing quality?', European Journal of Clinical Pharmacology, 57 333-341 (2001) [C1]
CitationsScopus - 16Web of Science - 15
Co-authorsMddah01
2001Newby DA, Hill SR, Barker B, Drew A, Henry DA, 'Drug information for consumers: should it be disease or medication specific? Results of a community survey', Australian and New Zealand Journal of Public Health, 25(6) 564-570 (2001) [C1]
CitationsScopus - 15Web of Science - 12
Co-authorsMddah01, David Newby
2001Treloar C, Hewitson P, Henderson KM, Harris G, Henry DA, McGrath K, 'Factors influencing the uptake of technologies to minimize perioperative allogeneic blood transfusion: an interview study of national and institutional stakeholders', Internal Medicine Journal, 31 230-236 (2001) [C1]
CitationsWeb of Science - 4
Co-authorsMddah01
2000Henry DA, Henderson KM, Fryer JL, Treloar C, McGrath K, Deveridge S, 'Use of interventions to minimise perioperative allogeneic blood transfusion in Australia', Medical Journal of Australia, 172 365-369 (2000) [C1]
Co-authorsMddah01
2000McManus M, Henry DA, Birkett B, 'Recent changes in the profile of prescription NSAID use in Australia', Medical Journal of Australia, 172 188 (2000) [C3]
CitationsWeb of Science - 4
Co-authorsMddah01
2000Moynihan M, Bero B, Ross-Degnan R, Henry DA, Lee L, Soumerai H, 'Coverage by the news media of the benefits and risks of medications', The New England Journal of Medicine, 342(22) 1645-1650 (2000) [C1]
CitationsScopus - 230Web of Science - 189
Co-authorsMddah01
2000Hill SR, Mitchell A, Henry DA, 'Problems with the Interpretation of Pharmacoeconomic Analyses', JAMA, 283(16) 2116-2121 (2000) [C1]
Co-authorsMddah01
2000Lowe J, Candish P, Henry DA, Wlodarcyk J, Fletcher P, 'Specialist or generalist care? A study of the impact of a selective admitting policy for patients with cardiac failure', International Journal for Quality in Health Care, 12(4) 339-345 (2000) [C1]
CitationsWeb of Science - 6
Co-authorsMddah01
2000Henry DA, McGettigan PG, 'Rofecoxib caused few endoscopic gastroduodenal ulcers than ibuprofen in osteoarthritis ( Laine L et al/Celecoxib was similar to naproxen for rheumatoid arthritis with fewer endoscopic ulcers (Simon LS et al) - Commentary', Evidence-Based Medicine (EBM), 5 74 (2000) [C3]
Co-authorsMddah01
2000Page J, Henry DA, 'Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients', Archives of Internal Medicine, 160(6) 777-784 (2000) [C1]
Co-authorsMddah01
1999Henry DA, Hill SR, 'Assessing new health technologies: lessons to be learned from drugs', Medical Journal of Australia, 171 554-556 (1999) [C1]
CitationsWeb of Science - 3
Co-authorsMddah01
1999Henry DA, Robertson J, 'Pharmacists' outreach visits and doctors' prescribing', Medical Journal of Australia, 170 460-461 (1999) [C2]
Co-authorsMddah01
1999Henry DA, Lopert R, 'Pharmacoeconomics and Policy Decisions: The Australian Health Care System', Clinical Therapeutics, 21(5) 909-915 (1999) [C1]
Co-authorsMddah01
1999Ferguson D, Blair A, Henry DA, Hisashige A, Huet C, Koopman-Van Gemert A, et al., 'Technologies to minimize blood transfusion in cardiac and orthopedic surgery', International Journal of Technology Assessment in Health Care, 15 (4) 717-728 (1999) [C1]
Co-authorsMddah01
1999Robertson J, Henry DA, Dobbins T, Sprogis A, Terry R, Ireland M, 'Prescribing patterns in general practice', Australian Family Physician, 28 (11) 1186-1190 (1999) [C1]
Co-authorsMddah01
1999McGettigan PG, Sly K, O'Connell DL, Hill SR, Henry DA, 'The Effects of Information Framing on the Practices of Physicians', Journal of General Internal Medicine, 14 633-642 (1999) [C1]
CitationsScopus - 77Web of Science - 61
Co-authorsMddah01
1999Nikolajevic-Sarunac J, Henry DA, O'Connell DL, Robertson J, 'Effects of information framing on the intentions of family physicians to prescribe long-term hormone replacement therapy', Journal of General Internal Medicine, 14 591-598 (1999) [C1]
CitationsScopus - 19Web of Science - 15
Co-authorsMddah01
1999O'Connell DL, Henry DA, Tomlins R, 'Randomised controlled trial of effect of feedback on general practitioners' prescribing in Australia', British Medical Journal, 318 507-511 (1999) [C1]
CitationsScopus - 100Web of Science - 85
Co-authorsMddah01
1999Henry DA, Hill SR, 'Meta-analysis - Its Role in Assessing Drug Safety', Pharmacoepidemiology and Drug Safety, 8(3) 167-168 (1999) [C2]
Co-authorsMddah01
1999Whitworth J, Lang DL, Henry DA, 'Cost-effectiveness Analysis in the Treatment of Hypertension: A Medical View', Clinical and Experimental Hypertension, 21(5-6) 999-1008 (1999) [C1]
Co-authorsMddah01
1998Henry DA, 'Commentary', ACP Journal Club, July/August 1998 10 (1998) [C3]
Co-authorsMddah01
1998Kerridge I, Lowe M, Henry DA, 'Ethics and Evidence-Based Medicine', British Medical Journal, 316 1151-1153 (1998) [C1]
Co-authorsMddah01
1998O'Connell DL, Robertson J, Henry DA, Gillespie W, 'A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects', Climacteric, 1 (2) 112-123 (1998) [C1]
CitationsScopus - 46
Co-authorsMddah01
1998Henry DA, Robertson J, O'Connell DL, Gillespie W, 'A systematic review of the skeletal effects of estrogen therapy in post-menopausal women. I. An assessment of the quality of randomized trials published between 1977 and 1995', Climacteric, 1 (2) 92-111 (1998) [C1]
CitationsScopus - 17
Co-authorsMddah01
1998Lowe J, Candish P, Henry DA, Wiodarcul J, Heller E, Fletcher P, 'Management and outcomes of congestive heart failure: a prospective study of hospitalised patients', Medical Journal of Australia, 168 115-118 (1998) [C1]
Co-authorsMddah01
1998Porteous J, Robertson J, Henry DA, 'Pharmaceutical security: a new research agenda?', The Medical Journal of Australia, 169 (5) 262-263 (1998) [C2]
Co-authorsMddah01
Show 113 more journal articles

Review (3 outputs)

YearCitationAltmetricsLink
2004Hill SR, Carless PA, Henry DA, Carlson JL, Herbert PC, McClelland DBL, Henderson KM, 'Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion', Cochrane Database of Systematic Reviews (2004) [D1]
CitationsScopus - 103
Co-authorsMddah01
2003Aaserud M, Dahlgren AT, Sturm H, Kosters JP, Hill SR, Furberg CD, et al., 'Pharmaceutical policies: effects on rational drug use', Cochrane Database of Systematic Reviews (2003) [D1]
Co-authorsMddah01
2003Henry DA, Moxey AJ, Carless PA, O'Connell DL, McClelland B, Henderson KM, et al., 'Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion', Cochrane Database of Systematic Reviews (2003) [D2]
CitationsScopus - 178Web of Science - 3
Co-authorsMddah01

Conference (4 outputs)

YearCitationAltmetricsLink
2004Moxey AJ, O'Connell DL, Deveridge SF, Treloar CJ, Henry DA, 'Involving older patients in decision making: a decision aid describing blood transfusion options for planned surgery', Abstracts and Proceedings of ERA 2004, Brisbane (2004) [E1]
Co-authorsMddah01
2001Carless PA, Hill SR, Henry DA, 'How low can we go? Lower thresholds for red cell transfusion', Destination downunder turning your thinking upside down : proceedings of the 4th International Conference on the Scientific Basis of Health Services, Sydney, Australia (2001) [E3]
Co-authorsMddah01
1998McGettigan PG, Henry DA, Page J, 'Adverse effects of non-steroidal anti-inflammatory drugs on the gastrointestinal tract and kidney: Relationship to cyclooxygenase-2 selectivity', Clinical significance and potential of selective COX-2 inhibitors, Phuket, Thailand (1998) [E2]
Co-authorsMddah01
1998Henry DA, Drew A, Beuzeville S, 'Adverse drug reactions in the gastrointestinal system attributed to ibuprofen', Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs, South San Francisco Conference Centre (1998) [E1]
Co-authorsMddah01
Show 1 more conference
Edit

Grants and Funding

Summary

Number of grants52
Total funding$12,678,379

Click on a grant title below to expand the full details for that specific grant.


20081 grants / $150,000

Pharmaceutical Promotion: Productive or Problematic?$150,000

Funding body: ARC (Australian Research Council)

Funding bodyARC (Australian Research Council)
Project TeamDoctor Evan Doran, Conjoint Professor David Henry, Mr Ray Moynihan
SchemeDiscovery Projects
RoleInvestigator
Funding Start2008
Funding Finish2008
GNoG0187476
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

20075 grants / $1,668,562

NIPH Capacity Building Infrastructure grant$1,472,398

Funding body: Hunter Medical Research Institute

Funding bodyHunter Medical Research Institute
Project TeamConjoint Professor David Henry, Professor Julie Byles, Professor John Wiggers, Conjoint Associate Professor Julia Lowe, Conjoint Professor David Durrheim
SchemeNIPH Capacity Building Infrastructure grant
RoleLead
Funding Start2007
Funding Finish2007
GNoG0187399
Type Of FundingOther Public Sector - State
Category2OPS
UONY

Moral Hazard and the Pharmaceutical Benefits Scheme$166,000

Funding body: ARC (Australian Research Council)

Funding bodyARC (Australian Research Council)
Project TeamDoctor Evan Doran, Conjoint Professor David Henry, Associate Professor G Salkeld, Doctor Jane Robertson
SchemeDiscovery Projects
RoleInvestigator
Funding Start2007
Funding Finish2007
GNoG0186334
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

Improving the quality of health news reports in the Australian media$20,000

Funding body: Hunter Medical Research Institute

Funding bodyHunter Medical Research Institute
Project TeamConjoint Professor David Henry, Doctor Amanda Wilson
SchemeProject Grant
RoleLead
Funding Start2007
Funding Finish2007
GNoG0187253
Type Of FundingContract - Aust Non Government
Category3AFC
UONY

The quality of health news reports about complementary and alternative medicine in Australian lay media$8,702

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor Alison Jones, Associate Professor Billie Bonevski, Conjoint Professor David Henry, Doctor Amanda Wilson
SchemePilot Grant
RoleInvestigator
Funding Start2007
Funding Finish2007
GNoG0187836
Type Of FundingInternal
CategoryINTE
UONY

Sri Lanka Medical Association 120th Annual Scientific Sessions, Colombo, 21/3/2007 - 24/3/2007$1,462

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor David Henry
SchemeTravel Grant
RoleLead
Funding Start2007
Funding Finish2007
GNoG0187382
Type Of FundingInternal
CategoryINTE
UONY

20065 grants / $696,860

Harmful or protective: low-dose selective cox-2 inhibitors and coronary or cerebrovascular occlusion$111,000

Funding body: National Heart Foundation of Australia

Funding bodyNational Heart Foundation of Australia
Project TeamConjoint Professor David Henry, Dr Patricia McGettigan
SchemeGrant-In-Aid
RoleLead
Funding Start2006
Funding Finish2006
GNoG0185371
Type Of FundingAust Competitive - Non Commonwealth
Category1NS
UONY

Harmful or protective? Low dose COX-2 inhibitors and coronary or cerebrovascular occlusion$20,000

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor David Henry, Dr Patricia McGettigan, Conjoint Professor Chris Levi
SchemeNear Miss Grant
RoleLead
Funding Start2006
Funding Finish2006
GNoG0186057
Type Of FundingInternal
CategoryINTE
UONY

Establishing a linked record system to optimise the use of longitudinal health-related datasets: illustrated by two studies of medication use$19,688

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamAssociate Professor Anne Young, Conjoint Associate Professor Lynne Parkinson, Professor Julie Byles, Conjoint Professor David Henry
SchemePilot Grant
RoleInvestigator
Funding Start2006
Funding Finish2006
GNoG0186687
Type Of FundingInternal
CategoryINTE
UONY

XIV Cochrane Colloquium, Dublin 2006, 23-27 October 2006$2,400

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor David Henry
SchemeTravel Grant
RoleLead
Funding Start2006
Funding Finish2006
GNoG0186970
Type Of FundingInternal
CategoryINTE
UONY

20053 grants / $3,357,466

External Evaluation of PBAC Submissions RFP 163/0304$3,221,378

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamDoctor Jane Robertson, Conjoint Professor David Henry
SchemeConsultancy/Tender
RoleInvestigator
Funding Start2005
Funding Finish2005
GNoG0184477
Type Of FundingOther Public Sector - Commonwealth
Category2OPC
UONY

The impact of International Trade Agreements on the regulation and provision of medicines in Australia$116,088

Funding body: ARC (Australian Research Council)

Funding bodyARC (Australian Research Council)
Project TeamConjoint Professor David Henry
SchemeDiscovery Projects
RoleLead
Funding Start2005
Funding Finish2005
GNoG0185098
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

Establishment of a Clinical Research Database for Hunter Stroke Service$20,000

Funding body: Hunter New England Area Health Service

Funding bodyHunter New England Area Health Service
Project TeamConjoint Professor David Henry
SchemeHunter Stroke Service
RoleLead
Funding Start2005
Funding Finish2005
GNoG0185608
Type Of FundingNot Known
CategoryUNKN
UONY

20042 grants / $29,586

Novel genetic and environmental risk factors in atherothrombosis: The role of variation in Cox-2, tpA and PAI-1 activity$28,000

Funding body: Hunter Medical Research Institute

Funding bodyHunter Medical Research Institute
Project TeamConjoint Professor Chris Levi, Conjoint Professor David Henry, Dr Patricia McGettigan, Professor John Attia, Professor Mark Parsons, Dr Michael Seldon, Professor Rodney Scott
SchemeResearch Grant
RoleInvestigator
Funding Start2004
Funding Finish2004
GNoG0183749
Type Of FundingContract - Aust Non Government
Category3AFC
UONY

The Cochrane Collaboration Colloquium, 2-6 October 2004, Canada$1,586

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor David Henry
SchemeTravel Grant
RoleLead
Funding Start2004
Funding Finish2004
GNoG0184822
Type Of FundingInternal
CategoryINTE
UONY

20031 grants / $161,000

COX-2 inhibitors and the development of unstable angina and myocardial infarction$161,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamConjoint Professor David Henry, Dr Patricia McGettigan, Associate Professor Suzanne Hill, Conjoint Associate Professor Julia Lowe
SchemeProject Grant
RoleLead
Funding Start2003
Funding Finish2003
GNoG0181781
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

20021 grants / $271,500

COX-2 inhibitors as a cause of heart and renal failure$271,500

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamConjoint Professor David Henry, Dr Patricia McGettigan, Associate Professor Suzanne Hill, Conjoint Associate Professor Julia Lowe, Conjoint Professor Ian Whyte
SchemeProject Grant
RoleLead
Funding Start2002
Funding Finish2002
GNoG0180892
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

20013 grants / $187,144

An investigation of the relationship between the pharmaceutical industry, medical profession and medical practitioners.$185,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamDr Ian Kerridge, Conjoint Professor David Henry, Associate Professor Suzanne Hill, Assoc. Prof P McNeill
SchemeProject Grant
RoleInvestigator
Funding Start2001
Funding Finish2001
GNoG0179679
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

Cochrane Colloquium (annual meeting) France 9-13 October, 2001$2,143

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor David Henry
SchemeTravel Grant
RoleLead
Funding Start2001
Funding Finish2001
GNoG0181555
Type Of FundingInternal
CategoryINTE
UONY

To Provide Independent Reviews of Draft Health Advisory Reports.$1

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamConjoint Associate Professor Rosemary Aldrich, Conjoint Associate Professor Julia Lowe, Conjoint Professor David Henry, Professor Julie Byles
SchemeConsultancy/Tender
RoleInvestigator
Funding Start2001
Funding Finish2001
GNoG0180846
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

20002 grants / $296,150

Alternatives to homologous blood transfusion - development of evidence-based decision aids.$213,697

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamConjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Doctor Sandra Deveridge
SchemeProject Grant
RoleLead
Funding Start2000
Funding Finish2000
GNoG0178462
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

Review of the risks associated with the use of NSAID's.$82,453

Funding body: Whitehall-Robbins Health Care Division

Funding bodyWhitehall-Robbins Health Care Division
Project TeamConjoint Professor David Henry
SchemeAmerican Home Products Corporation
RoleLead
Funding Start2000
Funding Finish2000
GNoG0180168
Type Of FundingInternational - Non Competitive
Category3IFB
UONY

19991 grants / $75,000

Pharmaceutical Affordability and the Quality Use of Medicines.$75,000

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamDoctor Evan Doran, Conjoint Professor David Henry
SchemePharmaceutical Education Program (PEP)
RoleInvestigator
Funding Start1999
Funding Finish1999
GNoG0178749
Type Of FundingOther Public Sector - Commonwealth
Category2OPC
UONY

19988 grants / $4,303,860

External Evaluation of PBAC Submissions$3,761,049

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamAssociate Professor Suzanne Hill, Conjoint Professor David Henry
SchemeConsultancy/Tender
RoleInvestigator
Funding Start1998
Funding Finish1998
GNoG0178712
Type Of FundingOther Public Sector - Commonwealth
Category2OPC
UONY

Integrated Care Program.$150,000

Funding body: Merck Sharp & Dohme Aust Pty Ltd

Funding bodyMerck Sharp & Dohme Aust Pty Ltd
Project TeamConjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Associate Professor Suzanne Hill
SchemeResearch Grant
RoleLead
Funding Start1998
Funding Finish1998
GNoG0178621
Type Of FundingContract - Aust Non Government
Category3AFC
UONY

The effect of different forms of information framing on helath care practices$122,786

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamConjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Associate Professor Suzanne Hill
SchemeProject Grant
RoleLead
Funding Start1998
Funding Finish1998
GNoG0177173
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

Developing Assessment Guidelines for the Medicare Services Advisory Committee$121,885

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamConjoint Professor David Henry
SchemeMedicare Services Advisory Committee
RoleLead
Funding Start1998
Funding Finish1998
GNoG0178236
Type Of FundingOther Public Sector - Commonwealth
Category2OPC
UONY

Development of a strategy to measure consumer participation in decisions about health service delivery$56,063

Funding body: NSW Health

Funding bodyNSW Health
Project TeamProfessor Jill Cockburn, Conjoint Professor David Henry, Associate Professor David Newby
SchemeMinisterial Advisory Committee - Quality in Health Care
RoleInvestigator
Funding Start1998
Funding Finish1998
GNoG0177842
Type Of FundingOther Public Sector - State
Category2OPS
UONY

Improving treatment decisions: accurate generalisation of clinical trial results$49,626

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamConjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Associate Professor Suzanne Hill, Conjoint Associate Professor Julia Lowe
SchemeProject Grant
RoleLead
Funding Start1998
Funding Finish1998
GNoG0177174
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

A Review of the Scientific Literature Concerning the Alternatives to Homologous Blood Donations$39,121

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamConjoint Professor David Henry
SchemeHealth Goals & Targets
RoleLead
Funding Start1998
Funding Finish1998
GNoG0177846
Type Of FundingOther Public Sector - Commonwealth
Category2OPC
UONY

Attendance and participation in the International Society of Technology Assessement in Health Care conference (ISTAHC) - Ottowa$3,330

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamConjoint Professor David Henry
SchemeMedicare Services Advisory Committee
RoleLead
Funding Start1998
Funding Finish1998
GNoG0177970
Type Of FundingOther Public Sector - Commonwealth
Category2OPC
UONY

19977 grants / $380,829

Review of the Consumer Drug Information Services$106,518

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamAssociate Professor David Newby, Conjoint Professor David Henry, Associate Professor Suzanne Hill
SchemePharmaceutical Education Program (PEP)
RoleInvestigator
Funding Start1997
Funding Finish1997
GNoG0177050
Type Of FundingOther Public Sector - Commonwealth
Category2OPC
UONY

Newcastle Prescriber Database$78,250

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamConjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Doctor Jane Robertson
SchemeGeneral Practice Evaluation Program (GPEP) (Defunct)
RoleLead
Funding Start1997
Funding Finish1997
GNoG0176055
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

The impact of specialists on prescribing by Australian general practitioners.$77,357

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamConjoint Professor David Henry, Doctor Arn Sprogis, Doctor Jane Robertson
SchemeGeneral Practice Evaluation Program (GPEP) (Defunct)
RoleLead
Funding Start1997
Funding Finish1997
GNoG0177040
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

Value of non-randomised studies for assessing the effectiveness of medical interventions$67,698

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamConjoint Professor David Henry, Conjoint Professor Dianne O'Connell
SchemeProject Grant
RoleLead
Funding Start1997
Funding Finish1997
GNoG0176234
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

Public Participation in Resource Allocation in Health$43,600

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamAssociate Professor David Newby, Conjoint Professor David Henry, Doctor Gloria Higginbottom, Professor Jill Cockburn, Associate Professor Suzanne Hill
SchemePharmaceutical Education Program (PEP)
RoleInvestigator
Funding Start1997
Funding Finish1997
GNoG0177552
Type Of FundingOther Public Sector - Commonwealth
Category2OPC
UONY

Evaluation of Hospital in the Home - design of protocol$4,906

Funding body: Macquarie Health Corporation

Funding bodyMacquarie Health Corporation
Project TeamConjoint Professor David Henry
SchemeResearch Grant
RoleLead
Funding Start1997
Funding Finish1997
GNoG0177004
Type Of FundingContract - Aust Non Government
Category3AFC
UONY

International Congress in Pharmacoepidemiology, Orlando, Florida, 24-27 August 1997$2,500

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor David Henry
SchemeTravel Grant
RoleLead
Funding Start1997
Funding Finish1997
GNoG0179481
Type Of FundingInternal
CategoryINTE
UONY

19963 grants / $97,608

Development, Testing and Refining of Indicators of Quality of Prescribing by General Practitioners$66,108

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamDoctor Jane Robertson, Conjoint Professor David Henry
SchemePHRDC Research Fellowship (Defunct)
RoleInvestigator
Funding Start1996
Funding Finish1996
GNoG0177702
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

Phamaceuticals Project Stage 2$20,000

Funding body: Consumers` Health Forum of Australia Inc.

Funding bodyConsumers` Health Forum of Australia Inc.
Project TeamConjoint Professor David Henry, Ms B Pekarsky
SchemeResearch Grant
RoleLead
Funding Start1996
Funding Finish1996
GNoG0176517
Type Of FundingContract - Aust Non Government
Category3AFC
UONY

An examination of the risk of sudden death during therapeutic use of thioridazine and desipramine by systematic review of randomised controlled trials$11,500

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamDr Nicholas Buckley, Conjoint Professor David Henry
SchemeProject Grant
RoleInvestigator
Funding Start1996
Funding Finish1996
GNoG0175828
Type Of FundingInternal
CategoryINTE
UONY

19954 grants / $734,067

The External Evaluation of PBAC Submissions$555,741

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamConjoint Professor David Henry
SchemePharmaceutical Education Program (PEP)
RoleLead
Funding Start1995
Funding Finish1995
GNoG0175545
Type Of FundingOther Public Sector - Commonwealth
Category2OPC
UONY

Assessing and increasing the generalisabiity of RCTs$107,448

Funding body: UK National Health Service

Funding bodyUK National Health Service
Project TeamConjoint Professor David Henry, Conjoint Professor Dianne O'Connell, Professor D Sackett, Mr P Glasziou
SchemeResearch & Development Program Grants
RoleLead
Funding Start1995
Funding Finish1995
GNoG0175419
Type Of FundingInternational - Non Competitive
Category3IFB
UONY

Conducting Analysis on Prescribing for Major Groups of Prescription Pharmacueticals which might explain the Variability in Prescribing Rates and Total ...$48,632

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamConjoint Professor David Henry
SchemeResearch & Development Grant (RADGAC)
RoleLead
Funding Start1995
Funding Finish1995
GNoG0175210
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

General Practitioners Beliefs Regarding Benefits and Risks of Hormone Replacement Therapy$22,246

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamConjoint Professor David Henry
SchemeResearch & Development Grant (RADGAC)
RoleLead
Funding Start1995
Funding Finish1995
GNoG0175208
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

19942 grants / $122,500

94GRANT. Speciality grant for Pharmacoepidemiology.$120,000

Funding body: Commonwealth Department of Health & Aged Care

Funding bodyCommonwealth Department of Health & Aged Care
Project TeamEmeritus Professor Anthony Smith, Conjoint Professor David Henry
SchemePharmaceutical Education Program (PEP)
RoleInvestigator
Funding Start1994
Funding Finish1994
GNoG0174635
Type Of FundingOther Public Sector - Commonwealth
Category2OPC
UONY

10 International Conference on Pharmacoepidemiology - Stockholm - 28-31 August 1994$2,500

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor David Henry
SchemeTravel Grant
RoleLead
Funding Start1994
Funding Finish1994
GNoG0175071
Type Of FundingInternal
CategoryINTE
UONY

19932 grants / $10,560

A Meta-Analysis of Falls in Old Age.$10,000

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamPaul Finucane, Conjoint Professor David Henry
SchemeNew Staff Grant
RoleInvestigator
Funding Start1993
Funding Finish1993
GNoG0172985
Type Of FundingInternal
CategoryINTE
UONY

'9th International Conference on Pharmacoepidemiology', JW Marriott Hotel, Washington DC, USA, 29 August - 1 September 1993$560

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor David Henry
SchemeTravel Grant
RoleLead
Funding Start1993
Funding Finish1993
GNoG0174397
Type Of FundingInternal
CategoryINTE
UONY

19922 grants / $135,687

Acute Renal Impairment And Cardiac Failure With Nsaids. A Community Study.$133,341

Funding body: NHMRC (National Health & Medical Research Council)

Funding bodyNHMRC (National Health & Medical Research Council)
Project TeamConjoint Professor David Henry
SchemeProject Grant
RoleLead
Funding Start1992
Funding Finish1992
GNoG0174270
Type Of FundingAust Competitive - Commonwealth
Category1CS
UONY

12th International Meeting of the International Society of Technology Assessment in Health Care, San Francisco, 23-26 June 1996$2,346

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor David Henry
SchemeTravel Grant
RoleLead
Funding Start1992
Funding Finish1992
GNoG0176432
Type Of FundingInternal
CategoryINTE
UONY
Edit

Research Supervision

Past Supervision

YearResearch Title / Program / Supervisor Type
2010A Preliminary Analysis of the Pharmaceutical Provisions in the Australia-United States Free Trade Agreement on Prescription Medicines in Australia
Public Health, Faculty of Health and Medicine
Principal Supervisor
2010Assessing the Quality of Health News Stories in the Australian Media Using the Media Doctor Website
Public Health, Faculty of Education and Arts
Co-Supervisor
2010Assessing the Quality of Health News Stories in the Australian Media Using the Media Doctor Website
Public Health, Faculty of Health and Medicine
Co-Supervisor
2007Evidence-Based Patient Decision Making: The Development of a Decision Aid on Blood Transfusion
Pharmacology, Faculty of Health and Medicine
Principal Supervisor
2005Evaluation of Aspects of the South African National Drug Policy: Hypertension, a Case Study
Pharmacology, Faculty of Health and Medicine
Co-Supervisor
2003Pharmaceutical Affordability and Quality Use of Medicines
Pharmacology, Faculty of Health and Medicine
Principal Supervisor
2002Public Participation in Health Care Decisions about Medicines
Pharmacology, Faculty of Health and Medicine
Principal Supervisor
Edit

Conjoint Professor David Henry

Position

Conjoint Professor
School of Medicine and Public Health
Faculty of Health and Medicine

Contact Details

Emaildavid.henry@newcastle.edu.au
Phone+14163716947 (Canada)
Fax(02) 4960 2088

Office

RoomNM2-535B
Edit